세계의 완전 인공심장(TAH) 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Total Artificial Heart cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

The Total Artificial Heart (TAH) market is experiencing rapid growth. This growth is primarily driven by several factors: first, the increasing incidence of cardiovascular diseases, particularly among the elderly population, leading to a rise in end-stage heart failure patients. Second, the shortage of heart transplant donors makes TAH an effective alternative, especially as a bridging therapy. Third, advancements in TAH technology, including miniaturization and improved durability and reliability, have made it a viable clinical option. Additionally, governmental and healthcare institutions' emphasis on cardiovascular disease treatment and insurance coverage for high-cost therapies have supported the development of the TAH market.

Despite the promising outlook, the TAH market faces several challenges and risks. First, the high cost of TAH limits its accessibility, particularly in developing countries. Second, long-term use of TAH may be associated with complications such as infections, thrombosis, and mechanical failures, impacting patient quality of life and treatment outcomes. Third, the complexity of TAH implantation surgery requires specialized medical teams, and postoperative management demands significant resources. Furthermore, the lifestyle changes required for long-term TAH use, including mobility restrictions and psychological adaptation, need to be carefully considered in patient care.

As TAH technology matures and clinical applications expand, downstream demand is becoming more diversified. Hospitals and medical centers, particularly heart transplant centers and intensive care units, are increasing their demand for TAH. Insurance companies are gradually expanding coverage for TAH, improving its accessibility for patients. Additionally, patient preferences for high-quality life have made comfort and convenience important considerations in TAH design and development. With the global aging population and the high incidence of cardiovascular diseases, the demand for TAH is expected to continue growing, establishing it as a crucial component in the treatment of heart failure in the coming decades.

This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Total Artificial Heart by region & country, by Type, and by Application.

The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.

Market Segmentation

By Company

• SynCardia Systems
• Carmat
• Abbott Laboratories
• Abiomed
• Berlin Heart

Segment by Type

• SynCardia
• Others

Segment by Application

• Dilated Cardiomyopathy
• Ischemic Cardiomyopathy
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Total Artificial Heart in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Total Artificial Heart Product Introduction
• 1.2 Global Total Artificial Heart Market Size Forecast
  • 1.2.1 Global Total Artificial Heart Sales Value (2020-2031)
  • 1.2.2 Global Total Artificial Heart Sales Volume (2020-2031)
  • 1.2.3 Global Total Artificial Heart Sales Price (2020-2031)
• 1.3 Total Artificial Heart Market Trends & Drivers
  • 1.3.1 Total Artificial Heart Industry Trends
  • 1.3.2 Total Artificial Heart Market Drivers & Opportunity
  • 1.3.3 Total Artificial Heart Market Challenges
  • 1.3.4 Total Artificial Heart Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Total Artificial Heart Players Revenue Ranking (2024)
• 2.2 Global Total Artificial Heart Revenue by Company (2020-2025)
• 2.3 Global Total Artificial Heart Players Sales Volume Ranking (2024)
• 2.4 Global Total Artificial Heart Sales Volume by Company Players (2020-2025)
• 2.5 Global Total Artificial Heart Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Total Artificial Heart Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Total Artificial Heart Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Total Artificial Heart
• 2.9 Total Artificial Heart Market Competitive Analysis
  • 2.9.1 Total Artificial Heart Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Total Artificial Heart Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Artificial Heart as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 SynCardia
  • 3.1.2 Others
• 3.2 Global Total Artificial Heart Sales Value by Type
  • 3.2.1 Global Total Artificial Heart Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Total Artificial Heart Sales Value, by Type (2020-2031)
  • 3.2.3 Global Total Artificial Heart Sales Value, by Type (%) (2020-2031)
• 3.3 Global Total Artificial Heart Sales Volume by Type
  • 3.3.1 Global Total Artificial Heart Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Total Artificial Heart Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Total Artificial Heart Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Total Artificial Heart Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Dilated Cardiomyopathy
  • 4.1.2 Ischemic Cardiomyopathy
  • 4.1.3 Others
• 4.2 Global Total Artificial Heart Sales Value by Application
  • 4.2.1 Global Total Artificial Heart Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Total Artificial Heart Sales Value, by Application (2020-2031)
  • 4.2.3 Global Total Artificial Heart Sales Value, by Application (%) (2020-2031)
• 4.3 Global Total Artificial Heart Sales Volume by Application
  • 4.3.1 Global Total Artificial Heart Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Total Artificial Heart Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Total Artificial Heart Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Total Artificial Heart Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Total Artificial Heart Sales Value by Region
  • 5.1.1 Global Total Artificial Heart Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Total Artificial Heart Sales Value by Region (2020-2025)
  • 5.1.3 Global Total Artificial Heart Sales Value by Region (2026-2031)
  • 5.1.4 Global Total Artificial Heart Sales Value by Region (%), (2020-2031)
• 5.2 Global Total Artificial Heart Sales Volume by Region
  • 5.2.1 Global Total Artificial Heart Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Total Artificial Heart Sales Volume by Region (2020-2025)
  • 5.2.3 Global Total Artificial Heart Sales Volume by Region (2026-2031)
  • 5.2.4 Global Total Artificial Heart Sales Volume by Region (%), (2020-2031)
• 5.3 Global Total Artificial Heart Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Total Artificial Heart Sales Value, 2020-2031
  • 5.4.2 North America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Total Artificial Heart Sales Value, 2020-2031
  • 5.5.2 Europe Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Total Artificial Heart Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Total Artificial Heart Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Total Artificial Heart Sales Value, 2020-2031
  • 5.7.2 South America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Total Artificial Heart Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Total Artificial Heart Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Total Artificial Heart Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Total Artificial Heart Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Total Artificial Heart Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Total Artificial Heart Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Total Artificial Heart Sales Value, 2020-2031
  • 6.3.2 United States Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Total Artificial Heart Sales Value, 2020-2031
  • 6.4.2 Europe Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Total Artificial Heart Sales Value, 2020-2031
  • 6.5.2 China Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Total Artificial Heart Sales Value, 2020-2031
  • 6.6.2 Japan Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Total Artificial Heart Sales Value, 2020-2031
  • 6.7.2 South Korea Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Total Artificial Heart Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Total Artificial Heart Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Total Artificial Heart Sales Value, 2020-2031
  • 6.9.2 India Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Total Artificial Heart Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 SynCardia Systems
  • 7.1.1 SynCardia Systems Company Information
  • 7.1.2 SynCardia Systems Introduction and Business Overview
  • 7.1.3 SynCardia Systems Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 SynCardia Systems Total Artificial Heart Product Offerings
  • 7.1.5 SynCardia Systems Recent Development
• 7.2 Carmat
  • 7.2.1 Carmat Company Information
  • 7.2.2 Carmat Introduction and Business Overview
  • 7.2.3 Carmat Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Carmat Total Artificial Heart Product Offerings
  • 7.2.5 Carmat Recent Development
• 7.3 Abbott Laboratories
  • 7.3.1 Abbott Laboratories Company Information
  • 7.3.2 Abbott Laboratories Introduction and Business Overview
  • 7.3.3 Abbott Laboratories Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Abbott Laboratories Total Artificial Heart Product Offerings
  • 7.3.5 Abbott Laboratories Recent Development
• 7.4 Abiomed
  • 7.4.1 Abiomed Company Information
  • 7.4.2 Abiomed Introduction and Business Overview
  • 7.4.3 Abiomed Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Abiomed Total Artificial Heart Product Offerings
  • 7.4.5 Abiomed Recent Development
• 7.5 Berlin Heart
  • 7.5.1 Berlin Heart Company Information
  • 7.5.2 Berlin Heart Introduction and Business Overview
  • 7.5.3 Berlin Heart Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Berlin Heart Total Artificial Heart Product Offerings
  • 7.5.5 Berlin Heart Recent Development

8 Industry Chain Analysis

• 8.1 Total Artificial Heart Industrial Chain
• 8.2 Total Artificial Heart Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Total Artificial Heart Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Total Artificial Heart Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer